- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased body length / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating free fatty acids level / IMPC
- increased circulating chloride level / IMPC
- decreased circulating glycerol level / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating glucose level / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating amylase level / IMPC
- decreased total body fat amount / IMPC
- increased circulating magnesium level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased fasting circulating glucose level / IMPC
C57BL/6N-Cpgi5563tm1.1(NCC)WCS/WtsiIeg
Status | Available to order |
EMMA ID | EM:14208 |
Citation information | RRID:IMSR_EM:14208 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Cpgi5563tm1.1(NCC)WCS/WtsiIeg |
Alternative name | EPD01018_3_B07 |
Strain type | |
Allele/Transgene symbol | Cpgi5563tm1.1(NCC)WCS |
Gene/Transgene symbol | Cpgi5563 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from undef ES clone EPD01018_3_B07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased fasting circulating glucose level / IMPC
- increased body length / IMPC
- increased lean body mass / IMPC
- decreased circulating glycerol level / IMPC
- increased circulating chloride level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased circulating amylase level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating magnesium level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased circulating glucose level / IMPC
- decreased total body fat amount / IMPC
- decreased circulating free fatty acids level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).